Various members of the JAK-STAT SFB consortium, PI Richard Moriggl among them, participated in the 4th International Conference on Cytokines in Cancer. It was a great pleasure to meet and discuss in person at one of the first conferences after the pandemic on the beautiful island of Chania.
Richard contributed by giving a talk with the title “Towards an understanding of the STAT5BN642H driver mutation in blood cancers and how to eliminate it“
Read more about the conference here.
The joint consortia meeting in Lyon/France between the ERAPerMed JAKSTAT-TARGET and the ERANET-PLL consortium (November 18 – 20, 2021) was the first in person meeting for all members since 2019. Most PIs could attend and the meeting resulted in very productive discussions and strengthened our collaborative efforts.
Thanks to all attending colleagues for this inspiring time in this beautiful city.
For more information on our international EU projects, please visit our consortium websites.
Despite the recurring lockdown measures that make working in research particularly challenging nowadays, PhD students from the Moriggl lab nevertheless participated in the Cytokine meeting 2020, that took place online from the 1st until the 4th of November.
https://seattle.cytokinesociety.org
Christina Wagner presented our model systems for JAK/STAT gain and loss of function mutations in the form of a lightning talk, which is a pre-recorded talk of 3 minutes/3 slides.
Tobias Suske recorded and uploaded an insightful talk about his research on STAT5BN642H driver mutations.
Tobias Suske receives Milstein Abstract Award for Cytokines 2020 Virtual Meeting
The Award Committee of the International Cytokine and Interferon Society (ICIS) selected Tobias for a Milstein Abstract Award in the amount of $500 in recognition of his presentation. The talk entitled “The Activating STAT5BN642H Driver Mutation Disrupts T Cell Development Progressing to T Cell Neoplasia” was given in the session “Structure-Function and Systems Biology of Cytokine Actions”.
Congratulations Christina and Tobi, and thank you ICIS for this great event! 🙂
At this year’s Vetmeduni Science Day, there were interesting talks, poster sessions from students, networking opportunities as well as awards given in recognition of outstanding scientific contributions from the previous year. Members of the Moriggl lab, Richard Moriggl and Heidi Neubauer, were very successful and received three awards.
Lab head Richard Moriggl was awarded with the ‘Vetmeduni Vienna ‘Scientist of the Year’ Award, non-clinical category: Highest number of citations’.
Heidi Neubauer was awarded with the ‘Vetmeduni Vienna ‘Young Scientist of the Year’ Award, non-clinical category: Highest number of citations’ and the ‘Vetmeduni Vienna ‘Young Scientist of the Year’ Award, non-clinical category: Most third-party funding’.
Read more on the Vetmeduni Science Day 2019.
From the 20th – 23rd October members of the Moriggl lab were excited to join the 7th Annual Meeting of the International Cytokine & Interferon Society that took place in the beautiful Hofburg in Vienna.
Our group was represented by well-received posters from Tobias Suske, Anna Orlova, Christina Maria Wagner and Helena Sorger. A highlight of the conference was an interesting selected short talk by Heidi Neubauer about the gain-of-function STAT5B N642H mutation as a driver of mature T cell leukemia/ lymphoma.
The Neubauer Lab 